Overview
Kert Sabbath is a Hematologist Oncology specialist and a Hematologist in New Haven, Connecticut. Dr. Sabbath is rated as an Experienced provider by MediFind in the treatment of Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Lung Adenocarcinoma, and Angiosarcoma.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
800 Howard Ave, New Haven, CT 06519
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
WPHPA Cancer And Blood Specialists Of New York
Dr. Lederman received her medical degree from Cornell Medical College and completed residency in Internal Medicine at The Mount Sinai Hospital in New York. After serving one year as Chief Resident in Internal Medicine at Elmhurst Hospital in Queens, she completed fellowship training in Hematology and Oncology at New York Medical College/Westchester Medical Center. She served New York Medical College as Assistant Clinical Professor for several years, as well as being an active member of the New York Blood Center Transfusion Service. Dr. Lederman is rated as a Distinguished provider by MediFind in the treatment of Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency. Her top areas of expertise are GTP Cyclohydrolase 1 Deficiency, Pseudocholinesterase Deficiency, Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency, and Deep Vein Thrombosis.
Northwell Health Physician Partners Cancer Center At Northern Westchester
Swati Sehgal is a Hematologist and an Oncologist in Mount Kisco, New York. Dr. Sehgal is rated as an Advanced provider by MediFind in the treatment of Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Familial Pancreatic Cancer.
WPHPA Cancer And Blood Specialists Of New York
Dr. Dan Costin is Director of the White Plains Hospital Center for Cancer Care. He has been practicing medical oncology and hematology in Westchester since 1993. He received his B.S. in biochemistry at the University of California in Los Angeles and his medical degree at the University of California in San Francisco. He completed his internal medicine residency at Beth Israel Hospital in Boston in 1990, his fellowship in medical oncology at the National Cancer Institute in Bethesda in 1991, and his fellowship in hematology at New York University in 1993. He has been an attending physician at White Plains Hospital since 1993 and served as section chief of the department of Hematology-Oncology from 1999 to 2007. Dr. Costin is rated as a Distinguished provider by MediFind in the treatment of Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency. His top areas of expertise are Paget Disease of the Breast, Chondrosarcoma, Osteosarcoma, and Angiosarcoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Sabbath isDistinguished. Learn about Angiosarcoma.
- Appendix CancerDr. Sabbath isDistinguished. Learn about Appendix Cancer.
- Breast CancerDr. Sabbath isDistinguished. Learn about Breast Cancer.
- Colorectal CancerDr. Sabbath isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Sabbath isDistinguished. Learn about Familial Colorectal Cancer.
- Inflammatory Breast CancerDr. Sabbath isDistinguished. Learn about Inflammatory Breast Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Sabbath isAdvanced. Learn about Anemia.
- Carcinoid SyndromeDr. Sabbath isAdvanced. Learn about Carcinoid Syndrome.
- Cervical CancerDr. Sabbath isAdvanced. Learn about Cervical Cancer.
- Congenital Antithrombin 3 Deficiency
- EGFR Positive Lung CancerDr. Sabbath isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acquired AgranulocytosisDr. Sabbath isExperienced. Learn about Acquired Agranulocytosis.
- Acute Eosinophilic PneumoniaDr. Sabbath isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Sabbath isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Sabbath isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation


